Synonyms: 2-[(2-Chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole; 2-[(2-Chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)indazole; CID 16734800; LXR-623; LXR623
Molecular Formula: C21H12ClF5N2
Molecular Weight: 422.78
Linear Structural Formula: C21H12ClF5N2
Purity: >=98% (HPLC)
Storage: room temp
Biochem Physiol Actions: WAY-252623 (LXR623) is an orally available, potent and highly selective Liver X receptors (LXRs) agonist that significantly reduced total and LDL-cholesterol. WAY-252623 reduces lesion progression in the murine LDLR(-/-) atherosclerosis model.
Legal Information: Sold for research purposes under agreement from Pfizer Inc.